Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 35,245 | N/A | N/A | N/A |
| Marketable Securities | 14,756 | N/A | N/A | N/A |
| Receivables | 42,169 | N/A | N/A | N/A |
| Other current assets | 5,927 | 0 | 0 | 0 |
| TOTAL | $98,096 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,447 | N/A | N/A | N/A |
| Investments And Advances | 389 | 0 | 0 | 0 |
| Intangibles | 10,454 | 0 | 0 | 0 |
| TOTAL | $12,291 | $N/A | $N/A | $N/A |
| Total Assets | $110,387 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 10,519 | 0 | 0 | 0 |
| Other current liabilities | 21,882 | N/A | N/A | N/A |
| TOTAL | $32,838 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 65,917 | 0 | 0 | 0 |
| TOTAL | $65,917 | $N/A | $N/A | $N/A |
| Total Liabilities | $98,755 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | N/A | 27,609 | N/A | N/A |
| Common Shares | 5,348 | N/A | N/A | N/A |
| Retained earnings | -236,532 | N/A | N/A | N/A |
| Other shareholders' equity | 2,848 | 0 | 0 | 0 |
| TOTAL | $11,632 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $110,387 | $0 | $0 | $0 |